Showing results (1-10 of 162) with videos related to
Sort By:
Pageof 17
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
What is Fitness in the Era of Targeted Agents?Alessandra TedeschiExpert Review of Hematology|June 21, 2013
'Use it again!': retherapy with bendamustine in indolent B-cell lymphoproliferative disordersMarco Montillo, Alessandra TedeschiHematology/Oncology Clinics of North America|May 28, 2023
The Management of Relapsed or Refractory Waldenström's MacroglobulinemiaRamón García-Sanz, Alessandra TedeschiExpert Review of Anticancer Therapy|October 6, 2006
Role of fludarabine in hematological malignanciesMarco Montillo, Francesca Ricci, Alessandra TedeschiCancer Treatment Reviews|January 13, 2017
Front-line treatment of CLL in the era of novel agentsTadeusz Robak, Stephan Stilgenbauer, Alessandra TedeschiBlood Reviews|February 10, 2007
CryoglobulinemiaAlessandra Tedeschi, Claudia Baratè, Ernesto Minola, et al.Mediterranean Journal of Hematology and Infectious Diseases|August 27, 2011
Therapy-Related Myeloid Neoplasms in Chronic Lymphocytic Leukemia and Waldenstrom's MacroglobulinemiaFrancesca Ricci, Alessandra Tedeschi, Marco Montillo, et al.Therapeutics and Clinical Risk Management|May 14, 2009
Fludarabine in the treatment of chronic lymphocytic leukemia: a reviewFrancesca Ricci, Alessandra Tedeschi, Enrica Morra, et al.Frontiers in Immunology|August 17, 2019
CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor VaccineRoberto S Accolla, Elise Ramia, Alessandra Tedeschi, et al.Expert Review of Hematology|November 19, 2010
Bendamustine: new perspective for an old drug in lymphoproliferative disordersMarco Montillo, Francesca Ricci, Alessandra Tedeschi, et al.Pageof 17